Published in Biomaterials on April 13, 2011
Direct-write assembly of 3D silk/hydroxyapatite scaffolds for bone co-cultures. Adv Healthc Mater (2012) 1.19
Cell sources for bone tissue engineering: insights from basic science. Tissue Eng Part B Rev (2011) 1.10
Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts. World J Stem Cells (2013) 0.98
Human induced pluripotent stem cell-derived mesenchymal stem cell seeding on calcium phosphate scaffold for bone regeneration. Tissue Eng Part A (2014) 0.94
Material strategies for creating artificial cell-instructive niches. Curr Opin Biotechnol (2012) 0.93
Application of biomaterials to advance induced pluripotent stem cell research and therapy. EMBO J (2015) 0.90
Adiponectin regulates bone marrow mesenchymal stem cell niche through a unique signal transduction pathway: an approach for treating bone disease in diabetes. Stem Cells (2015) 0.88
Stepwise differentiation of pluripotent stem cells into osteoblasts using four small molecules under serum-free and feeder-free conditions. Stem Cell Reports (2014) 0.88
Induced pluripotent stem cell-derived mesenchymal stem cell seeding on biofunctionalized calcium phosphate cements. Bone Res (2013) 0.85
Bone tissue engineering via human induced pluripotent, umbilical cord and bone marrow mesenchymal stem cells in rat cranium. Acta Biomater (2015) 0.84
Layer-by-layer paper-stacking nanofibrous membranes to deliver adipose-derived stem cells for bone regeneration. Int J Nanomedicine (2015) 0.80
Craniofacial reconstruction with induced pluripotent stem cells. J Craniofac Surg (2012) 0.80
Stem Cells and Calcium Phosphate Cement Scaffolds for Bone Regeneration. J Dent Res (2014) 0.79
Bioactive factors for tissue regeneration: state of the art. Muscles Ligaments Tendons J (2012) 0.79
MiR-34a Promotes Osteogenic Differentiation of Human Adipose-Derived Stem Cells via the RBP2/NOTCH1/CYCLIN D1 Coregulatory Network. Stem Cell Reports (2016) 0.78
Osteogenesis and neurogenesis: a robust link also for language evolution. Front Cell Neurosci (2015) 0.77
Epigenetically Modified Bone Marrow Stromal Cells in Silk Scaffolds Promote Craniofacial Bone Repair and Wound Healing. Tissue Eng Part A (2015) 0.77
Runx2/DICER/miRNA Pathway in Regulating Osteogenesis. J Cell Physiol (2016) 0.76
Perinatal stem cells: A promising cell resource for tissue engineering of craniofacial bone. World J Stem Cells (2015) 0.76
Peptide drugs accelerate BMP-2-induced calvarial bone regeneration and stimulate osteoblast differentiation through mTORC1 signaling. Bioessays (2016) 0.75
SATB2-Nanog axis links age-related intrinsic changes of mesenchymal stem cells from craniofacial bone. Aging (Albany NY) (2016) 0.75
3D-tracking the regenerative potential of the mandible with micro-CTs. Oral Maxillofac Surg (2014) 0.75
Biological Evaluation of Flexible Polyurethane/Poly l-Lactic Acid Composite Scaffold as a Potential Filler for Bone Regeneration. Materials (Basel) (2017) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Generation of germline-competent induced pluripotent stem cells. Nature (2007) 32.77
Reprogramming of human somatic cells to pluripotency with defined factors. Nature (2007) 30.84
Establishment in culture of pluripotential cells from mouse embryos. Nature (1981) 30.49
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature (2007) 28.24
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol (2007) 21.93
Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell (2007) 21.58
Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A (1981) 18.96
Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science (2008) 14.26
Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A (2008) 13.09
Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell (2008) 12.45
Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature (2008) 12.21
Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell (2009) 11.65
Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature (2009) 9.29
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol (2007) 9.04
Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A (2008) 7.52
Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res (2009) 7.09
Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells (2009) 5.69
Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature (2009) 5.37
Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone (2003) 4.61
SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell (2006) 4.01
Tissue-engineered bone regeneration. Nat Biotechnol (2000) 3.84
Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation (2008) 3.11
Bone graft materials. An overview of the basic science. Clin Orthop Relat Res (2000) 3.10
Clostridium infections associated with musculoskeletal-tissue allografts. N Engl J Med (2004) 3.08
Stem cell-based tissue engineering with silk biomaterials. Biomaterials (2006) 2.88
Bone graft and bone graft substitutes: a review of current technology and applications. J Appl Biomater (1991) 2.74
Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation (2010) 2.39
Differentiation of embryonic stem cells into adipocytes in vitro. J Cell Sci (1997) 2.33
A network connecting Runx2, SATB2, and the miR-23a~27a~24-2 cluster regulates the osteoblast differentiation program. Proc Natl Acad Sci U S A (2010) 2.29
Identification of SATB2 as the cleft palate gene on 2q32-q33. Hum Mol Genet (2003) 2.25
Silk implants for the healing of critical size bone defects. Bone (2005) 2.22
SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression. Genes Dev (2003) 2.17
Phenotypic correction of murine hemophilia A using an iPS cell-based therapy. Proc Natl Acad Sci U S A (2009) 2.02
The biology of bone grafting. J Am Acad Orthop Surg (2005) 1.85
Novel transcription factor Satb2 interacts with matrix attachment region DNA elements in a tissue-specific manner and demonstrates cell-type-dependent expression in the developing mouse CNS. Eur J Neurosci (2005) 1.75
In vitro and in vivo characteristics of PCL scaffolds with pore size gradient fabricated by a centrifugation method. Biomaterials (2006) 1.61
Satb2 haploinsufficiency phenocopies 2q32-q33 deletions, whereas loss suggests a fundamental role in the coordination of jaw development. Am J Hum Genet (2006) 1.50
Regulation of osteoblast differentiation by Runx2. Adv Exp Med Biol (2010) 1.47
Adipogenic differentiation of human induced pluripotent stem cells: comparison with that of human embryonic stem cells. FEBS Lett (2009) 1.43
Bone tissue engineering with premineralized silk scaffolds. Bone (2008) 1.43
Osteogenic and chondrogenic differentiation of embryonic stem cells in response to specific growth factors. Bone (2005) 1.41
Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells. FASEB J (2010) 1.38
Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both in vitro and in vivo. Stem Cells (2011) 1.29
Mandibular repair in rats with premineralized silk scaffolds and BMP-2-modified bMSCs. Biomaterials (2009) 1.29
Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Calcif Tissue Int (1995) 1.27
Hoxa-2 restricts the chondrogenic domain and inhibits bone formation during development of the branchial area. Development (1998) 1.24
Resveratrol promotes osteogenic differentiation and protects against dexamethasone damage in murine induced pluripotent stem cells. Stem Cells Dev (2010) 1.17
Osterix overexpression in mesenchymal stem cells stimulates healing of critical-sized defects in murine calvarial bone. Tissue Eng (2007) 1.14
Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction. Stem Cells (2009) 1.12
Lubiprostone reverses the inhibitory action of morphine on intestinal secretion in guinea pig and mouse. J Pharmacol Exp Ther (2010) 1.08
Osterix enhances BMSC-associated osseointegration of implants. J Dent Res (2009) 1.02
Recent advances in gene delivery for structural bone allografts. Tissue Eng (2007) 0.97
Bone sialoprotein promotes bone metastasis of a non-bone-seeking clone of human breast cancer cells. Anticancer Res (2004) 0.91
Growth hormone treatment promotes guided bone regeneration in rat calvarial defects. Eur J Orthod (2001) 0.79
The mutational landscape of head and neck squamous cell carcinoma. Science (2011) 16.88
Pembrolizumab for the treatment of non-small-cell lung cancer. N Engl J Med (2015) 10.12
Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol (2007) 9.67
Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell (2009) 8.62
Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell (2006) 8.48
Silk-based biomaterials. Biomaterials (2003) 7.72
Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell (2011) 7.41
HDAC2 negatively regulates memory formation and synaptic plasticity. Nature (2009) 6.96
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet (2011) 5.73
Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells (2009) 5.69
Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med (2013) 5.29
Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study. Lancet (2012) 4.98
Randomized trial of oral teriflunomide for relapsing multiple sclerosis. N Engl J Med (2011) 4.93
Mechanism of silk processing in insects and spiders. Nature (2003) 4.85
Dissolvable films of silk fibroin for ultrathin conformal bio-integrated electronics. Nat Mater (2010) 4.62
The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors. Cancer Cell (2009) 4.47
DisProt: the Database of Disordered Proteins. Nucleic Acids Res (2006) 4.46
A genetically encoded fluorescent reporter reveals oscillatory phosphorylation by protein kinase C. J Cell Biol (2003) 4.38
Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet (2009) 4.28
Silk as a Biomaterial. Prog Polym Sci (2007) 4.13
CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol (2004) 4.08
The developmental dynamics of the maize leaf transcriptome. Nat Genet (2010) 4.02
New opportunities for an ancient material. Science (2010) 3.95
Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin. Biomaterials (2005) 3.87
Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts. Cell Rep (2013) 3.85
Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer. J Clin Oncol (2009) 3.58
In vitro degradation of silk fibroin. Biomaterials (2005) 3.56
Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes. Toxicol Sci (2007) 3.52
Materials fabrication from Bombyx mori silk fibroin. Nat Protoc (2011) 3.45
A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature (2009) 3.44
In vivo degradation of three-dimensional silk fibroin scaffolds. Biomaterials (2008) 3.39
A requirement for CARMA1 in TCR-induced NF-kappa B activation. Nat Immunol (2002) 3.38
Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments. Proc Natl Acad Sci U S A (2004) 3.31
PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. Mol Cell (2012) 3.28
Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials (2006) 3.27
Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells (2010) 3.24
Reference genome sequence of the model plant Setaria. Nat Biotechnol (2012) 3.21
Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes (2009) 3.17
Priming in systemic plant immunity. Science (2009) 3.11
Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell (2010) 3.08
Crystal structure of the cytoskeleton-associated protein glycine-rich (CAP-Gly) domain. J Biol Chem (2002) 3.01
Detecting cAMP-induced Epac activation by fluorescence resonance energy transfer: Epac as a novel cAMP indicator. EMBO Rep (2004) 2.98
Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science (2012) 2.98
Prophylactic antibiotics cannot reduce infected pancreatic necrosis and mortality in acute necrotizing pancreatitis: evidence from a meta-analysis of randomized controlled trials. Am J Gastroenterol (2007) 2.98
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res (2004) 2.96
Villification: how the gut gets its villi. Science (2013) 2.94
Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease. Blood (2009) 2.91
Stem cell-based tissue engineering with silk biomaterials. Biomaterials (2006) 2.88
PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-kappa B. J Biol Chem (2002) 2.88
The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease. Pediatr Allergy Immunol (2007) 2.81
The inflammatory responses to silk films in vitro and in vivo. Biomaterials (2005) 2.79
Porous 3-D scaffolds from regenerated silk fibroin. Biomacromolecules (2004) 2.77
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses. Nat Biotechnol (2009) 2.76
Revising the WHO verbal autopsy instrument to facilitate routine cause-of-death monitoring. Glob Health Action (2013) 2.69
Subcellular dynamics of protein kinase A activity visualized by FRET-based reporters. Biochem Biophys Res Commun (2006) 2.66
Functional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NF-kappaB and caspase-1. FEBS Lett (2002) 2.66
Atmospheric new particle formation enhanced by organic acids. Science (2004) 2.62
Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector. Stem Cells (2010) 2.62
Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Circulation (2009) 2.62
Cell differentiation by mechanical stress. FASEB J (2001) 2.56
PNPASE regulates RNA import into mitochondria. Cell (2010) 2.54
Salt-sensitive hypertension is triggered by Ca2+ entry via Na+/Ca2+ exchanger type-1 in vascular smooth muscle. Nat Med (2004) 2.52
Structure and properties of silk hydrogels. Biomacromolecules (2004) 2.50
A physically transient form of silicon electronics. Science (2012) 2.47
Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell (2013) 2.45
beta2-adrenergic receptor signaling and desensitization elucidated by quantitative modeling of real time cAMP dynamics. J Biol Chem (2007) 2.42
Inferring reputation promotes the evolution of cooperation in spatial social dilemma games. PLoS One (2012) 2.41
Coupled ferredoxin and crotonyl coenzyme A (CoA) reduction with NADH catalyzed by the butyryl-CoA dehydrogenase/Etf complex from Clostridium kluyveri. J Bacteriol (2007) 2.38
Potential markers that complement expression of CA125 in epithelial ovarian cancer. Gynecol Oncol (2005) 2.34
A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN. Proc Natl Acad Sci U S A (2008) 2.34
Influence of the period-dependent circadian clock on diurnal, circadian, and aperiodic gene expression in Drosophila melanogaster. Proc Natl Acad Sci U S A (2002) 2.33
Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature (2012) 2.32
Clinical correlates in an experimental model of repetitive mild brain injury. Ann Neurol (2013) 2.32
First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy. Cancer Discov (2012) 2.31
Vascularization strategies for tissue engineering. Tissue Eng Part B Rev (2009) 2.31
Influence of chemotherapy on EGFR mutation status among patients with non-small-cell lung cancer. J Clin Oncol (2012) 2.31
Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. Cancer Discov (2013) 2.29
Providing research results to participants: attitudes and needs of adolescents and parents of children with cancer. J Clin Oncol (2009) 2.28
Regulation of silk material structure by temperature-controlled water vapor annealing. Biomacromolecules (2011) 2.24
Silk matrix for tissue engineered anterior cruciate ligaments. Biomaterials (2002) 2.22
Silk implants for the healing of critical size bone defects. Bone (2005) 2.22
Tunneling and coupled motion in the Escherichia coli dihydrofolate reductase catalysis. J Am Chem Soc (2004) 2.21
Electrospinning Bombyx mori silk with poly(ethylene oxide). Biomacromolecules (2002) 2.20
Waterproof AlInGaP optoelectronics on stretchable substrates with applications in biomedicine and robotics. Nat Mater (2010) 2.20
Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma. Am J Gastroenterol (2010) 2.20
Optimizing the fMRI data-processing pipeline using prediction and reproducibility performance metrics: I. A preliminary group analysis. Neuroimage (2004) 2.19
Antagonistic HLH/bHLH transcription factors mediate brassinosteroid regulation of cell elongation and plant development in rice and Arabidopsis. Plant Cell (2009) 2.17
Sonication-induced gelation of silk fibroin for cell encapsulation. Biomaterials (2007) 2.15
Re-emerging superconductivity at 48 kelvin in iron chalcogenides. Nature (2012) 2.13
The anterior cruciate ligament remnant: to leave it or not? Arthroscopy (2013) 2.13
Engineering adipose-like tissue in vitro and in vivo utilizing human bone marrow and adipose-derived mesenchymal stem cells with silk fibroin 3D scaffolds. Biomaterials (2007) 2.13
Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proc Natl Acad Sci U S A (2013) 2.09
Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents. Am Heart J (2010) 2.09
c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma. Hepatology (2014) 2.04
Macrophage responses to silk. Biomaterials (2003) 2.04